Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

Shenzhen Stock Exchange 002932.SZ

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Market Capitalization on January 14, 2025: USD 567.55 M

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Market Capitalization is USD 567.55 M on January 14, 2025, a -24.78% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Wuhan Easy Diagnosis Biomedicine Co.,Ltd. 52-week high Market Capitalization is USD 754.50 M on January 15, 2024, which is 32.94% above the current Market Capitalization.
  • Wuhan Easy Diagnosis Biomedicine Co.,Ltd. 52-week low Market Capitalization is USD 507.82 M on February 05, 2024, which is -10.52% below the current Market Capitalization.
  • Wuhan Easy Diagnosis Biomedicine Co.,Ltd. average Market Capitalization for the last 52 weeks is USD 614.22 M.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
Shenzhen Stock Exchange: 002932.SZ

Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

CEO Ms. Chen Li Li
IPO Date July 10, 2018
Location China
Headquarters Wuhan Optics Valley International Biomed
Employees 1,547
Sector Health Care
Industries
Description

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and diagnostic equipment in China and internationally. Its products portfolio includes molecular diagnostic products, such as drug metabolism genetic testing and pathogen nucleic acid detection kits; and immunodiagnostic and blood gas diagnosis products. The company also provides emergency and critical illness information solutions, including information software products, supporting hardware, and certification consulting services; and third-party medical inspection services. It offers products in the areas of cardiovascular, kidney, infectious, diabetes, endocrine and metabolic, obstetrics, and gynecology diseases, as well as prenatal and postnatal care, health checkups, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection. The company was founded in 2008 and is based in Wuhan, China.

Similar companies

300677.SZ

Intco Medical Technology Co., Ltd.

USD 3.37

3.57%

002030.SZ

Daan Gene Co., Ltd.

USD 0.79

3.04%

688298.SS

Zhejiang Orient Gene Biotech Co., Ltd.

USD 3.93

2.90%

688068.SS

Beijing Hotgen Biotech Co., Ltd.

USD 9.57

0.77%

002432.SZ

Andon Health Co., Ltd.

USD 5.45

2.10%

StockViz Staff

January 15, 2025

Any question? Send us an email